Hostname: page-component-8448b6f56d-42gr6 Total loading time: 0 Render date: 2024-04-18T00:39:26.768Z Has data issue: false hasContentIssue false

Potential for the current National Healthcare Safety Network (NHSN) >3 days after admission definition of laboratory-identified, healthcare-facility–onset, Clostridioides difficile infection (HO-CDI) to overestimate rates

Published online by Cambridge University Press:  24 January 2020

Shruti Puri
Affiliation:
Department of Medicine, Division of Infectious Diseases at the Medical University of South Carolina, Charleston, South Carolina
Heather Y. Hughes
Affiliation:
Department of Medicine, Division of Infectious Diseases at the Medical University of South Carolina, Charleston, South Carolina Ralph H. Johnson Veterans’ Affairs Medical Center, Charleston, South Carolina
Monica D. McCrackin
Affiliation:
Ralph H. Johnson Veterans’ Affairs Medical Center, Charleston, South Carolina
Robert Williford
Affiliation:
Department of Medicine, Division of Infectious Diseases at the Medical University of South Carolina, Charleston, South Carolina
Mulugeta Gebregziabher
Affiliation:
Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina
Cassandra D. Salgado
Affiliation:
Department of Medicine, Division of Infectious Diseases at the Medical University of South Carolina, Charleston, South Carolina
Scott R. Curry*
Affiliation:
Department of Medicine, Division of Infectious Diseases at the Medical University of South Carolina, Charleston, South Carolina
*
Author for correspondence: Scott R. Curry, E-mail: currysr@musc.edu

Abstract

Healthcare-facility–onset C.difficile LabID events are defined as positive stool samples collected >3 days after hospitalization. Using a definition of >72 hours, we found that 84 of 1013 cases (8.3%) identified as C. difficile LabID events were collected between 48 and 72 hours after admission.

Type
Concise Communication
Copyright
© 2020 by The Society for Healthcare Epidemiology of America. All rights reserved

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

PREVIOUS PRESENTATION: An abstract of this manuscript (abstract #340) was presented at the SHEA Spring 2018 Conference, on April 19, 2018, in Portland, Oregon.

References

Durkin, MJ, Baker, AW, Dicks, KV, et al.A comparison between National Healthcare Safety Network laboratory-identified event reporting versus traditional surveillance for Clostridium difficile infection. Infect Control Hosp Epidemiol 2015;36:125131.CrossRefGoogle ScholarPubMed
Gase, KA, Haley, VB, Xiong, K, Van Antwerpen, C, Stricof, RL.Comparison of two Clostridium difficile surveillance methods: National Healthcare Safety Network’s laboratory-identified event reporting module versus clinical infection surveillance. Infect Control Hosp Epidemiol 2013;34:284290.CrossRefGoogle Scholar
Multidrug-resistant organisms and Clostridioides difficile infection (MDRO/CDI) module. Centers for Disease Control and Prevention website. https://www.cdc.gov/nhsn/PDFs/pscManual/12pscMDRO_CDADcurrent.pdf. Published 2019. Accessed January 8, 2020.Google Scholar
Samore, MH, DeGirolami, PC, Tlucko, A, Lichtenberg, DA, Melvin, ZA, Karchmer, AW.Clostridium difficile colonization and diarrhea at a tertiary-care hospital. Clin Infect Dis 1994;18:181187.CrossRefGoogle ScholarPubMed
Shim, JK, Johnson, S, Samore, MH, Bliss, DZ, Gerding, DN.Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea. Lancet 1998;351:633636.CrossRefGoogle ScholarPubMed
Marra, AR, Edmond, MB, Ford, BA, Herwaldt, LA, Algwizani, AR, Diekema, DJ.Failure of risk-adjustment by test method for C. difficile laboratory-identified event reporting. Infect Control Hosp Epidemiol 2017;38:109111.CrossRefGoogle ScholarPubMed